Ultragenyx Pharmaceutical Goodwill and Intangible Assets 2012-2024 | RARE
Ultragenyx Pharmaceutical goodwill and intangible assets for the quarter ending June 30, 2024 were $0.211B, a 3.95% increase year-over-year.
- Ultragenyx Pharmaceutical goodwill and intangible assets for 2023 were $0.211B, a 3.01% increase from 2022.
- Ultragenyx Pharmaceutical goodwill and intangible assets for 2022 were $0.205B, a 16.73% increase from 2021.
- Ultragenyx Pharmaceutical goodwill and intangible assets for 2021 were $0.175B, a 0.19% decline from 2020.